Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke

NCT02149875 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Acute Cerebral Stroke Within 12 Hours for the First Time

Interventions

DRUG: Dl-3-n-butylphthalide
DRUG: Cerebrolysin
DRUG: Placebo

Sponsor

Shanghai 6th People's Hospital